An international collaboration published a complete, annotated genomic sequencing of wheat used in making bread, a widely grown staple crop and major source of nutrition worldwide. . . . → Read More: Bread Wheat Genome Sequenced
|
|||||
A group of newborn infants with genetic disorders that went undetected in standard testing will receive genomic sequencing in a clinical study of its safety and feasibility. . . . → Read More: Genomic Sequencing for Newborns Studied in Clinical Trial 
A treatment that silences the actions of RNA and reverses damage to nerves from a rare inherited neurological disease was approved by the Food and Drug Administration. . . . → Read More: FDA Approves RNA-Interference Nerve Disease Therapy 
Drug maker Allergan is acquiring the rights from Editas Medicine to develop an application of the genome-editing technology Crispr for the inherited eye disease Leber congenital amaurosis type 10. . . . → Read More: Allergan Licensing Crispr for Inherited Eye Disease 
A process for quickly determining genetic mutations behind brain tumors and delivering a treatment addressing those mutations is shown to extend the survival of lab mice induced with those tumors. . . . → Read More: Precision Medicine Technique Devised for Brain Tumors 
A recently published study shows a genetic test for abnormal number of chromosomes conducted with women seeking to become pregnant helps improve their chances for in-vitro fertilization success. . . . → Read More: Genetic Testing Shown to Improve IVF Success [Updated]  One comment - (Comments are closed)  New products  biomedical, genomics, life sciences, medical device, software 
A biotechnology company and research lab are evaluating a modified skin bacteria as a treatment for Netherton syndrome, a rare inherited skin disease affecting mainly infants and young children. . . . → Read More: Engineered Bacteria Studied for Rare Inherited Skin Disorder 2 comments - (Comments are closed) Finance, Joint ventures/collaborations, New products biomedical, biotechnology, entrepreneurs, genomics, grant, life sciences, NIH, pharmaceuticals, preclinical, university 
An experimental drug designed to silence a protein associated with inherited forms of amyotrophic lateral sclerosis, or ALS, is shown in tests with lab rodents to extend survival and reverse some neuromuscular damage. . . . → Read More: Experimental Drug Extends Survival, Reverses Inherited ALS Damage Comments are closed New products biomedical, biotechnology, clinical trials, genomics, life sciences, NIH, pharmaceuticals, preclinical, university 
Consumer genetics company 23andMe signed a 4-year agreement to help drug maker GlaxoSmithKline find more precise drug targets and recruit clinical trial participants likely to respond to treatments. . . . → Read More: GSK, 23andMe Ink Precision Meds Discovery Deal One comment - (Comments are closed) Finance, Joint ventures/collaborations biomedical, clinical trials, equity, Europe, genomics, investment, life sciences, medical device, pharmaceuticals, U.K. 
A research consortium in the semiconductor industry and National Science Foundation are supporting a series of projects investigating interactions between biology and circuits for data transfer and storage. . . . → Read More: NSF, Industry Group Fund Bio-Based Semiconductor R&D Comments are closed Joint ventures/collaborations biotechnology, chemistry, computer science, engineering, genomics, grant, life sciences, materials science, nanotechnology, NSF, physical sciences, physics, semiconductors, university |
One Blood Test Fits All Diseases A Thinking Person’s Artificial Intelligence Do You Want Your Bacon CRISPR? Health Care, Precisely One Person at a Time Let Guinea Pigs be Guinea Pigs Look Out Pharma. The Tech Industry is After You |
||||
|
Copyright © 2018 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
